Intellectual Property India Publishes Patent Application for 'Fibroblast Activation Protein-Targeted Compositions And Methods Of Use Thereof' Filed by Ratio Therapeutics, Inc.

MUMBAI, India, March 14 -- Intellectual Property India has published a patent application (202617015576 A) filed by Ratio Therapeutics, Inc., Boston, on Feb. 12, for 'fibroblast activation protein-targeted compositions and methods of use thereof.'

Inventor(s) include Amor-Coarasa, Alejandro; Babich, John, W.; Dimagno, Stephen; and Orcutt, Kelly.

The application for the patent was published on March 13, under issue no. 11/2026.

According to the abstract released by the Intellectual Property India: "Disclosed is a compound represented by the following structural formula (I): or a pharmaceutically acceptable salt thereof. The variables of structural formula (I) are described herein. The compound of the invention can be attached to chelating...